Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Oventus executes material agreements in the US to enable widespread adoption of ‘lab in lab’ model in sleep and dental channels (ASX:OVN)

Key points: Oventus signs material agreements with VirtuOx, Carestream Dental and Lyon Dental Agreements enable patients to receive end-to-end sleep apnoea consultations, diagnosis, pres...read more

Oventus announce First US Agreements Signed with Sleep Medicine Groups (ASX:OVN)

Oventus enters into first agreements with American sleep medicine groups to deliver the O2Vent® Sleep Treatment Platform to patients under the ‘lab in lab’ model Key points: ...read more

Oventus Medical, First US Agreements Signed with Sleep Medicine Groups (ASX:OVN)

Oventus Medical Ltd or the Company (ASX: OVN) is pleased to announce it has signed its first material contract with an American sleep medicine group which will adopt the Company’s O2Vent® ...read more

Oventus Medical, Investor Presentation (ASX:OVN)

To view the presentation, download the attached PDF.

Oventus announces entry into initial agreements with Canadian sleep medicine groups who will deliver the O2Vent® Sleep Treatment Platform to patients under the ‘lab in lab’ model (ASX:OVN)

Key points: Oventus signs first material agreements with sleep medicine groups in Canada for its O2Vent® Sleep Treatment Platform which treats obstructive sleep apnoea (OSA) The excl...read more

Oventus Announce ExVentTM registered for sale in Australia and Canada to complement efficacy of O2Vent oral device (ASX:OVN)

Key points: ExVentTM registered with Australia’s Therapeutic Goods Administration Enables sale of the unique valve which is an accessory to Oventus’ O2Vent® oral therapeu...read more

Oventus announces positive clinical data published in SLEEP® (ASX:OVN)

SLEEP® journal paper shows Oventus ExVentTM and OnePAPTM valves used in combination with mandibular advancement splints like O2Vent® reduce sleep apnoea for a substantial proportion of patient...read more

Oventus Medical, Appendix 3B - New Issue Announcement (ASX:OVN)

Appendix 3B - New issue announcement, application for quotation of additional securities and agreement. For further information please download the attached PDF:

Oventus Announces Appendix 3Y - Change of Director’s Interest Notice (ASX:OVN)

Appendix 3Y - Change of Directors interest Notice For further information please download the attached PDF:

Oventus Announces Appendix 3Y Change of Director’s Interest Notice (ASX:OVN)

Appendix 3Y - Change of Director's Interest Notice For further information please download the attached PDF:

Oventus Announces North Carolina Sleep and Dental Groups adopt O2 Vent (ASX:OVN)

Key points: In line with Oventus’ strategy of engaging with the sleep community to drive adoption of Oventus Airway Technology, a collaborative model has been implemented through w...read more

Oventus Releases Investor Presentation (ASX:OVN)

Oventus is an Australian medical device company with a proprietary technology for the treatment of obstructive sleep apnea (OSA). Our focus is on treating those patients that are not being, or canno...read more

Oventus Announces Investor Information Sessions (ASX:OVN)

Brisbane, Australia 30 April 2019: Oventus Medical Ltd (ASX: OVN) is pleased to invite investors to attend a series of information sessions being held across Brisbane, Sydney and Melbourne in May. ...read more

Oventus Announces Quarterly Business Review (ASX:OVN)

Highlights Cash receipts increase to $100,000 in quarter ended 31 March 2019, up from $47,000 in prior quarter Cash position of $5.1 million as at 31 March 2019 O2 Vent® Optima successfully ...read more

Oventus, Half Yearly Report and Accounts (ASX:OVN)

To view the report, download the attached PDF.

Viewing: 76 - 90 of 200 Previous | Next